Art

J-GLOBAL ID：201102276492093225   Reference number：11A1220682

Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study

全身性エリテマトーデスにおけるトシリズマブ:非盲検第I相用量増加研究から得られた安全性,予備的有効性,循環血中形質細胞に及ぼす影響に関するデータ

Author (11)： ILLEI Gabor G. (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  SHIROTA Yuko (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  YARBORO Cheryl H. (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  DARUWALLA Jimmy (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  TACKEY Edward (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  TAKADA Kazuki (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  LIPSKY Peter E. (National Inst. Of Arthritis And Musculoskeletal And Skin Diseases) ,  ILLEI Gabor G. (National Inst. Of Dental And Craniofacial Res.) ,  SHIROTA Yuko (National Inst. Of Dental And Craniofacial Res.) ,  FLEISHER Thomas (Clinical Center, NIH) ,  BALOW James E. (National Inst. Of Diabetes And Digestive And Kidney Diseases, NIH, Maryland)
Material： Arthritis & Rheumatism  (Arthritis Rheum)
Volume： 62  Issue： 2  Page： 542-552  Publication year： Feb. 2010 
JST Material Number： C0784B  ISSN： 0004-3591  Document type： Article
Country of issue： United States (USA)  Language： ENGLISH (EN)

Terms in the title (11)： 全身性エリテマトーデス ,  トシリズマブ ,  盲 ,  I相 ,  用量 ,  研究 ,  安全性 ,  有効性 ,  循環 ,  血 ,  形質細胞